PTC Therapeutics Ends Utreloxastat Development After Rare Neurodegenerative Disease Trial Misses Goal, Analyst Maintains Outperform With Focus On Sepiapterin, Huntingtons Programs
| AZBCX Fund | USD 24.76 0.12 0.48% |
Slightly above 62% of Allianzgi Small-cap's investor base is looking to short. The analysis of overall sentiment of trading Allianzgi Small Cap Blend mutual fund suggests that many investors are alarmed at this time. Allianzgi Small-cap's investing sentiment can be driven by a variety of factors including economic data, Allianzgi Small-cap's earnings reports, geopolitical events, and overall market trends.
Allianzgi |
On Tuesday, PTC Therapeutics Inc revealed data from the global Phase 2 placebo-controlled CardinALS study of Utreloxastat in amyotrophic lateral sclerosis patients. The study did not meet its primary endpoint of slowing disease progression on the composite ALSFRS-R and mortality analysis. Also Read FDA Grants Conditional Approval For PTC Therapeutics Gene Therapy As First Ever With Direct Administration In Brain While modest numerical benefit was recorded on the primary endpoint,
Read at finance.yahoo.com
 |
Allianzgi Small-cap Fundamental Analysis
We analyze Allianzgi Small-cap's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allianzgi Small-cap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allianzgi Small-cap based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Allianzgi Small is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Allianzgi Small Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Allianzgi Small-cap mutual fund to make a market-neutral strategy. Peer analysis of Allianzgi Small-cap could also be used in its relative valuation, which is a method of valuing Allianzgi Small-cap by comparing valuation metrics with similar companies.
Peers
Allianzgi Small-cap Related Equities
| USCBX | California Bond | 0.29 | ||||
| TTRBX | Ambrus Core | 0.20 | ||||
| TFBIX | Maryland Tax-free | 0.20 | ||||
| CFNLX | The National | 0.16 | ||||
| LTXFX | Limited Term | 0.13 | ||||
| ARTFX | Artisan High | 0.00 | ||||
| SWSFX | Ultra-short Fixed | 0.00 |
Other Information on Investing in Allianzgi Mutual Fund
Allianzgi Small-cap financial ratios help investors to determine whether Allianzgi Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allianzgi with respect to the benefits of owning Allianzgi Small-cap security.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |